中国美容医学2024,Vol.33Issue(1) :181-184.

外用糖皮质激素引起的皮肤萎缩及其防治研究进展

Research Progress on Skin Atrophy Induced by Topical Glucocorticoids and Its Prevention and Treatment

杨丹丹 沈杰 赵琪 王雍 孙振亮 胡振林
中国美容医学2024,Vol.33Issue(1) :181-184.

外用糖皮质激素引起的皮肤萎缩及其防治研究进展

Research Progress on Skin Atrophy Induced by Topical Glucocorticoids and Its Prevention and Treatment

杨丹丹 1沈杰 2赵琪 1王雍 1孙振亮 2胡振林1
扫码查看

作者信息

  • 1. 上海大学医学院 上海 200444
  • 2. 上海市奉贤区中心医院中心实验室 上海 201499
  • 折叠

摘要

皮肤萎缩是外用糖皮质激素最常见的副作用之一.外用糖皮质激素引起皮肤萎缩的机制包括:抑制角质形成细胞增殖、加快其分化成熟、抑制表皮脂质合成、抑制成纤维细胞增殖,减少胶原蛋白和透明质酸钠等细胞外基质合成等.近年来,对其副作用的防治主要集中在研发糖皮质激素受体的选择性调节剂、靶向抑制促萎缩基因及相关的信号通路、联合使用其他核受体的激动剂等方面,本文就其研究进展综述如下.

Abstract

Skin atrophy is one of the most prevalent side-effects of topical glucocorticosteroids.The mechanisms involved in topical glucocorticoids-induced skin atrophy include suppressing keratinocyte proliferation,accelerating their maturation,inhibiting the synthesis of epidermal lipids,suppressing fibroblast proliferation,reducing the synthesis of extracellular matrix such as collagen and hyaluronic acid,etc.In recent years,the research on the prevention and treatment of this side-effect mainly focuses on the development of selective modulators of glucocorticoid receptor,targeted inhibition of atrophogenes and related signal pathways,combination with other nuclear receptor agonists.

关键词

糖皮质激素/皮肤萎缩/副作用/选择性调节剂/促萎缩基因/核受体激动剂

Key words

glucocorticoids/skin atrophy/side-effect/selective activators/modulators/atrophogenes/nuclear receptor agonist

引用本文复制引用

出版年

2024
中国美容医学
西安交通大学第四军医大学

中国美容医学

CSTPCD
影响因子:1.006
ISSN:1008-6455
被引量1
参考文献量34
段落导航相关论文